Open AccessAdoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors
Author(s) -
A. Pavlova,
Michael Maschan,
В. Б. Пономарев
Publication year - 2017
Publication title -
onkogematologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.118
H-Index - 3
eISSN - 2413-4023
pISSN - 1818-8346
DOI - 10.17650/1818-8346-2017-12-1-17-32
Subject(s) - chimeric antigen receptor , immunotherapy , genetically engineered , cd19 , antigen , immunology , medicine , clinical trial , cell therapy , genetically modified organism , genetic enhancement , disease , receptor , t cell , cancer research , immune system , biology , cell , gene , biochemistry , genetics